Medical economics

COVID-19: Governments must stop vaccine cost secrecy

Globally affordable COVID-19 vaccines will not be accessible until governments stop allowing vaccine companies to keep their manufacturing costs secret, according to a new paper published by the Journal of the Royal Society ...

Medications

Powerful new antivirals for COVID are coming

(HealthDay)—People newly infected with COVID-19 might soon have access to what essentially is Tamiflu for the novel coronavirus, a breakthrough that experts say would drastically alter the course of the ongoing pandemic.

Medications

Lanadelumab in hereditary angioedema: Added benefit not proven

The monoclonal antibody lanadelumab has been approved in Europe since 2015 as a long-term prophylaxis to prevent attacks of hereditary angioedema. Since this is a rare disease, the Federal Joint Committee (G-BA) initially ...

Vaccination

WHO urges COVID vaccine makers to keep prices down

The World Health Organization on Wednesday urged COVID-19 vaccine manufacturers to keep their prices low and affordable, after reports that two producers will raise the cost they are charging the EU.

page 10 from 40